Law360, New York (February 08, 2012, 7:08 PM ET) -- A New Jersey federal judge on Wednesday blocked Mylan Pharmaceuticals Inc. from launching a generic version of Warner Chilcott PLC’s anti-acne medication Doryx.
U.S. District Judge William J. Martini issued a temporary restraining order, with the agreement of both parties, in order for the court to complete the impending trial, consider the evidence and render a decision.
Mylan had sought to market a generic version of the Doryx 150-milligram doxycycline hyclate delayed-release tablet products, according to the suit.
Judge Martini also issued an identical TRO in...
Mylan Can't Launch Doryx Generic Just Yet
To view the full article, take a free trial now.
